A ground-breaking case in the High Court will decide this week whether the UK’s only gender identity development service (GIDS) for under-18s will be allowed to continue to prescribe puberty blockers for children as young as 10-years-old. The case against the Tavistock and Portman NHS trust, which runs GIDs, is currently conducting its own internal review as a response to the growing controversy surrounding its practice.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in